OIIM [O2MICRO INTERNATIONAL] SC 13G: 67107W100 CUSIP No. 13G Page 2 of 5
[67107W100 CUSIP No. 13G Page 2 of 5 Pages]
MR [Mindray Medical International] SC 13G: (Original Filing)
[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 3,024,194 NUMBER OF -----------------------------------------------------------------]
SVA [SINOVAC BIOTECH] SC 13G: (Original Filing)
[SCHEDULE 13G (Amendment No. )* Sinovac Biotech Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this]
MR [Mindray Medical International] SC 13G: 1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS.
[1 NAMES OF REPORTING PERSONS. I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY). EARNEST Partners, LLC ------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS) (a) [ ] (b) [ ] ------------------------------------------------------------------------------- 3 SEC USE ONLY ------------------------------------------------------------------------------- 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Georgia ------------------------------------------------------------------------------- 5 SOLE VOTING POWER 3,024,194 NUMBER OF -----------------------------------------------------------------]
SVA [SINOVAC BIOTECH] SC 13G: SCHEDULE 13G (Amendment No. )* Sinovac Biotech Ltd.
[SCHEDULE 13G (Amendment No. )* Sinovac Biotech Ltd. (Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) x Rule 13d-1(b) o Rule 13d-1(c) o Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person’s initial filing on this]
JD [JD.com] SC 13G: (Original Filing)
[1 The Reporting Persons hold both Class A Ordinary Shares and American Depositary Shares, which may be exchanged for Class A Ordinary Shares, par value $0.00002, at a 1:2 ratio. Unless otherwise indicated, this Schedule 13G reports the Reporting Persons' beneficial ownership of Class A Ordinary Shares and American Depositary Shares on an aggregate basis. CUSIP No 47215P106 1. NAME]
TEDU [Tarena International] SC 13G: (Original Filing)
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to]
JD [JD.com] SC 13G: 1 The Reporting Persons hold both Class A
[1 The Reporting Persons hold both Class A Ordinary Shares and American Depositary Shares, which may be exchanged for Class A Ordinary Shares, par value $0.00002, at a 1:2 ratio. Unless otherwise indicated, this Schedule 13G reports the Reporting Persons' beneficial ownership of Class A Ordinary Shares and American Depositary Shares on an aggregate basis. CUSIP No 47215P106 1. NAME]
TEDU [Tarena International] SC 13G: *The remainder of this cover page shall be
[*The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to]
BABA [Alibaba] SC 13G: (Original Filing)
[JOINT FILING AGREEMENT Dated: February 17, 2015 (remainder of page intentionally left blank) JACK YUN MA JOSEPH C. TSAI CLARA WU MING-HUA APN LTD.] [POWER OF ATTORNEY (remainder of page intentionally left blank) th day of February, 2015. JACK YUN MA JOSEPH C. TSAI CLARA WU MING-HUA] [SCHEDULE 13G (Amendment No. )* Alibaba Group Holding Limited (Name of Issuer) American Depositary Shares (ADS), each representing one ordinary share, par value $0.000025 per share (Title of Class of Securities) 01609W102** (CUSIP Number) December 31, 2014 (Date of Event Which Requires Filing of this Statement) o Rule 13d-1(b) o Rule 13d-1(c) x Rule 13d-1(d) *The remainder of this cover]
